by Scott Harwood | Oct 25, 2023
Joseph Mikhael, MD, Chief Medical Officer at the International Myeloma Foundation talks about the M-POWER program. Transcription: At the International Myeloma Foundation, it’s a privilege for me to work there, one of the greatest...
by CheckRare Staff | Oct 24, 2023
Mike Snape, PhD, chief scientific officer at AMO Pharma talks about his journey to studying myotonic dystrophy. Transcription: My name is Mike Snape. I am a PhD Neuroscientist by training. I started my career with an interest in the health conditions of older...
by CheckRare Staff | Oct 23, 2023
Monica Gadelha, PhD, Professor of Medicine at the University of Rio De Janeiro discusses symptoms and how symptoms for Acromegaly patients are managed. Transcription: There are two main problems with managing acromegaly. First, let me define...
by CheckRare Staff | Oct 19, 2023
Elijah Stacy, author of “A Small If”, founder of Destroy Duchenne, and Capricor Therapeutics Consultant says…” , says “You can’t hold anything back if you’re going to tell a story that’s supposed to help people overcome their suffering”. ...
by CheckRare Staff | Oct 18, 2023
Mike Snape, PhD, chief scientific officer at AMO Pharma explains the different methods currently being used to treat and quell the effects of myotonic dystrophy. Transcription: Currently, patients with myotonic dystrophy have non-pharmacological support. They...
